Cardinal Health, Inc (CAH) concluded trading on Thursday at a closing price of $127.01, with 3.45 million shares of worth about $437.9 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 10.77% during that period and on March 06, 2025 the price saw a loss of about -0.32%. Currently the company’s common shares owned by public are about 242.00M shares, out of which, 240.91M shares are available for trading.
Stock saw a price change of -0.36% in past 5 days and over the past one month there was a price change of 1.47%. Year-to-date (YTD), CAH shares are showing a performance of 7.39% which increased to 12.76% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $93.17 but also hit the highest price of $132.84 during that period. The average intraday trading volume for Cardinal Health, Inc shares is 2.31 million. The stock is currently trading -0.26% below its 20-day simple moving average (SMA20), while that difference is up 1.56% for SMA50 and it goes to 13.06% higher than SMA200.
Cardinal Health, Inc (NYSE: CAH) currently have 242.00M outstanding shares and institutions hold larger chunk of about 88.31% of that.
The stock has a current market capitalization of $30.68B and its 3Y-monthly beta is at 0.68. PE ratio of stock for trailing 12 months is 23.71, while it has posted earnings per share of $5.36 in the same period. Its PEG reads 2.47 and has Quick Ratio of 0.54. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CAH, volatility over the week remained 2.26% while standing at 1.77% over the month.
Stock’s fiscal year EPS is expected to rise by 5.66% while it is estimated to increase by 12.78% in next year. EPS is likely to grow at an annualized rate of 9.60% for next 5-years, compared to annual growth of -5.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on February 05, 2025 offering a Buy rating for the stock and assigned a target price range of between $140 and $150 to it. Coverage by TD Cowen stated Cardinal Health, Inc (CAH) stock as a Buy in their note to investors on January 08, 2025, suggesting a price target of $144 for the stock. On January 07, 2025, Evercore ISI Upgrade their recommendations, while on January 06, 2025, BofA Securities Upgrade their ratings for the stock with a price target of $145. Stock get an Equal weight rating from Wells Fargo on December 13, 2024.
